From Numbers to Narrative: Mastering the Art of PK Presentation Guide From Numbers to Narrative: Mastering the Art of PK Presentation Master PK data reporting with a structured guide to presenting pharmacokinetic results clearly and turning…CertaraMarch 20, 2026
Pediatric Drug Development and Pharmacometrics: Key Questions Sponsors Must Answer Guide Pediatric Drug Development and Pharmacometrics: Key Questions Sponsors Must Answer Download Certara’s expert guide on pharmacometrics and pediatric drug development. Learn how modeling, MIDD, and…CertaraMarch 19, 2026
Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026 Blog Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026 Explore how model-informed drug development and AI are advancing pharmacoequity and shaping the future of…CertaraMarch 11, 2026
Modeling Platinum-Induced Nephrotoxicity: A PK/TD Analysis of Calbindin and B2-Microglobulin Urinary Biomarkers Webinar Modeling Platinum-Induced Nephrotoxicity: A PK/TD Analysis of Calbindin and B2-Microglobulin Urinary Biomarkers CertaraMarch 9, 2026
Navigate GxP Compliance in the Cloud with Confidence Guide Navigate GxP Compliance in the Cloud with Confidence Master SaaS GxP compliance with risk-based computer system validation (CSV) aligned to GAMP 5, FDA,…CertaraMarch 6, 2026
ADC First-in-Human (FIH) Dose Selection: Designing FIH Studies for Success Blog ADC First-in-Human (FIH) Dose Selection: Designing FIH Studies for Success Optimize ADC First-in-Human Dose Selection with model-informed strategies and exposure–response insights to design safer, more…CertaraMarch 3, 2026
Apotekarsocieteten Clinical Pharmacology Strategies in Drug Development Conference Apotekarsocieteten Clinical Pharmacology Strategies in Drug Development Danielle PillsburyMarch 2, 2026
Phoenix Roadshow 2026 – Raleigh/Durham Live Events Phoenix Roadshow 2026 – Raleigh/Durham CertaraMarch 2, 2026